Inventor · disambiguated record
David Tice
Also filed as: TICE DAVID · TICE DAVID A · TICE DAVID ALAN
9 granted patents·6 pending applications·34 citations·filing 2001–2024
84Inventor score
Top patents by PatentIndex Score
15 records- 0192US10988546B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2018·Granted Apr 27, 2021·8 cites·14 claims
- 0288US11608375B2Binding molecules specific for ASCT2 and uses thereofMEDIMMUNE LLC·Filed 2020·Granted Mar 21, 2023·2 cites·16 claims
- 0388US10829554B2Binding molecules specific for ASCT2 and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Nov 10, 2020·5 cites·20 claims
- 0487US9220775B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Dec 29, 2015·15 cites·39 claims
- 0579US10040857B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 7, 2018·3 cites·56 claims
- 0676US2024294666A1BCMA Monoclonal Antibody-Drug ConjugateMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0769US11912782B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2021·Granted Feb 27, 2024·0 cites·19 claims
- 0866US9212231B2TRAIL R2-specific multimeric scaffoldsBACA MANUEL·Filed 2011·Granted Dec 15, 2015·1 cites·24 claims
- 0965US11091554B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2018·Granted Aug 17, 2021·0 cites·20 claims
- 1053US2009304721A1Toxin conjugated eph receptor antibodiesMEDLMMUNE INC·Filed 2006·Application pending·0 cites
- 1152US11305012B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2014·Granted Apr 19, 2022·0 cites·14 claims
- 1250US2002173461A1Methods for enhancing the efficacy of cancer therapyFiled 2001·Application pending·0 cites
- 1347US2022218835A1Combination therapyMEDIMMUNE LLC·Filed 2020·Application pending·0 cites
- 1444US2011280892A1Toxin conjugated eph receptor antibodiesKINCH MICHAEL S·Filed 2010·Application pending·0 cites
- 1539US2019367605A1Binding Molecules Specific For ASCT2 And Uses ThereofMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Tice files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →